Stereotaxis, Inc. (STXS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Stereotaxis, Inc. (STXS) is down 18.7% since the beginning of the year. At $2 per share, STXS is trading 47.9% below its 52-week high of $4. Investors who bought $1,000 worth of STXS shares 5 years ago would now be looking at an investment worth $186.

Stereotaxis, Inc. (STXS) has returned -18.70% so far this year and -8.33% over the past 12 months. Over the last ten years, STXS has returned 7.01% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Aug 12, 2004, STXS's average daily return is +0.09%, while the average monthly return is +0.79%. At this rate, an investment would double in approximately 7.3 years.

Historically, 46% of months were positive and 54% were negative. The best month was Jul 2013 with a return of +238.1%, while the worst month was Aug 2011 at -60.0%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 11 months.

On a daily basis, STXS closed higher 44% of trading days. The best single day was Jul 30, 2013 with a return of +228.7%, while the worst single day was Aug 9, 2011 at -58.2%.

Stereotaxis, Inc. has an annualized alpha of 11.10%, beta of 1.07, and R2 of 0.04 versus S&P 500 Index. Calculated based on daily prices since August 12, 2004.

• This stock participated in 195.46% of S&P 500 Index downside but only 104.42% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.04 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

STXS ranks 36 for risk / return — below 36% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Stereotaxis, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Stereotaxis, Inc. was 99.68%, occurring on Nov 14, 2016. The portfolio has not yet recovered.

The current Stereotaxis, Inc. drawdown is 98.84%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Stereotaxis, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Stereotaxis, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.